Reviewing Establishment Labs (NASDAQ:ESTA) & Tauriga Sciences (OTCMKTS:TAUG)

Establishment Labs (NASDAQ:ESTA) and Tauriga Sciences (OTCMKTS:TAUG) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations.

Analyst Ratings

This is a breakdown of current ratings for Establishment Labs and Tauriga Sciences, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	1	1	6	0	2.63
Tauriga Sciences	0	0	0	0	0.00

Establishment Labs presently has a consensus price target of $78.86, suggesting a potential upside of 15.39%. Given Establishment Labs’ stronger consensus rating and higher possible upside, equities research analysts clearly believe Establishment Labs is more favorable than Tauriga Sciences.

Institutional and Insider Ownership

72.9% of Establishment Labs shares are held by institutional investors. 11.1% of Establishment Labs shares are held by company insiders. Comparatively, 3.5% of Tauriga Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Establishment Labs and Tauriga Sciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-43.45%	-235.45%	-22.83%
Tauriga Sciences	N/A	N/A	N/A

Earnings and Valuation

This table compares Establishment Labs and Tauriga Sciences”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$166.02 million	11.96	-$84.60 million	($2.84)	-24.06
Tauriga Sciences	N/A	N/A	N/A	N/A	N/A

Tauriga Sciences has lower revenue, but higher earnings than Establishment Labs.

Summary

Establishment Labs beats Tauriga Sciences on 6 of the 9 factors compared between the two stocks.

About Establishment Labs

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

About Tauriga Sciences

Tauriga Sciences, Inc. produces and sells cannabidiol infused chewing gum under the Tauri-Gum brand name. It also develops anti-nausea products; and skin care products include CBD facemasks; CBD daily moisturizer; CBD anti-wrinkle dream, hand, and foot cream with hemp seed oil; CBD massage and body oil; CBD body revive roll-on; CBD transdermal patch; and CBD body spray. In addition, the company offers rainbow deluxe sampler pack, CBD non-GMO dietary supplements, and CBD scented bath bombs. It sells its products through e-commerce, distributors, and wholesale channels. The company has a collaboration agreement with Aegea Biotechnologies, Inc. to develop a rapid, multiplexed COVID-19 (novel coronavirus) test. Tauriga Sciences, Inc. was founded in 2001 and is headquartered in Wappingers Falls, New York.